Regeneron Pharmaceuticals on Pace for Record High Close -- Data Talk
13 Outubro 2023 - 12:57PM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $849.20,
up $10.71 or 1.28%
--Would be new all-time high (Based on available data back to
April 2, 1991)
--On pace for largest percent increase since Oct. 5, 2023, when
it rose 1.98%
--Currently up seven of the past eight days
--Currently up four consecutive days; up 2.09% over this
period
--Longest winning streak since Aug. 14, 2023, when it rose for
six straight trading days
--Up 3.19% month-to-date
--Up 17.7% year-to-date; on pace for best year since 2021, when
it rose 30.72%
--Up 15.37% from 52 weeks ago (Oct. 14, 2022), when it closed at
$736.06
--Would be a new 52-week closing high
--Up 24.79% from its 52-week closing low of $680.49 on Jan. 9,
2023
--Traded as high as $853.97; new all-time intraday high (Based
on available data back to April 2, 1991)
--Up 1.85% at today's intraday high; largest intraday percent
increase since Oct. 5, 2023, when it rose as much as 2.04%
--Sixth best performer in the Nasdaq 100 today
All data as of 11:25:11 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 13, 2023 11:42 ET (15:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024